A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors

NCT01351519 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Limited staff available for enrollment and limited availability of drug

Conditions

Malignant Glioma
Glioma
Glioblastoma
Glioblastoma Multiforme
Astrocytoma

Interventions

DRUG: Aminolevulinic Acid

Sponsor

MultiCare Health System Research Institute